Cited by

• Sustained-Release Vildagliptin 100 mg in Type 2 Diabetes Mellitus: A Review.

  Sridhar GR, Pandit K, Warrier S, Birla A. Sridhar GR, et al. Cureus. 2023 May 18;15(5):e39204. doi: 10.7759/cureus.39204. eCollection 2023 May. Cureus. 2023. PMID: 37378205 Free PMC article. Review.
• Co-crystals as a new approach to multimodal analgesia and the treatment of pain.

  Almansa C, Frampton CS, Vela JM, Whitelock S, Plata-Salamán CR. Almansa C, et al. J Pain Res. 2019 Sep 4;12:2679-2689. doi: 10.2147/JPR.S208082. eCollection 2019. J Pain Res. 2019. PMID: 31564960 Free PMC article.
• Acceptability of a first-line anti-tuberculosis formulation for children: qualitative data from the SHINE trial.

  Wademan DT, Busakwe L, Nicholson TJ, van der Zalm M, Palmer M, Workman J, Turkova A, Crook AM, Thomason MJ, Gibb DM, Seeley J, Hesseling A, Hoddinott G. Wademan DT, et al. Int J Tuberc Lung Dis. 2019 Dec 1;23(12):1263-1268. doi: 10.5588/ijtld.19.0115. Int J Tuberc Lung Dis. 2019. PMID: 31931909 Free PMC article.
• Multi-ligand molecular docking, simulation, free energy calculations and wavelet analysis of the synergistic effects between natural compounds baicalein and cubebin for the inhibition of the main protease of SARS-CoV-2.

  Li H, Komori A, Li M, Chen X, Yang AWH, Sun X, Liu Y, Hung A, Zhao X, Zhou L. Li H, et al. J Mol Liq. 2023 Mar 15;374:121253. doi: 10.1016/j.molliq.2023.121253. Epub 2023 Jan 16. J Mol Liq. 2023. PMID: 36694691 Free PMC article.
• Supercomputing Multi-Ligand Modeling, Simulation, Wavelet Analysis and Surface Plasmon Resonance to Develop Novel Combination Drugs: A Case Study of Arbidol and Baicalein Against Main Protease of SARS-CoV-2.

  Li H, Su H, Komori A, Yang S, Luo H, Yang AWH, Sun X, Li H, Hung A, Zhao X. Li H, et al. Pharmaceuticals (Basel). 2025 Jul 17;18(7):1054. doi: 10.3390/ph18071054. Pharmaceuticals (Basel). 2025. PMID: 40732341 Free PMC article.